These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1940120

  • 1. Vigabatrin in refractory epilepsy in adults and its application in children.
    Dam M.
    J Child Neurol; 1991; Suppl 2():S25-9. PubMed ID: 1940120
    [Abstract] [Full Text] [Related]

  • 2. Neuropathologic findings in patients receiving long-term vigabatrin therapy for chronic intractable epilepsy.
    Cannon DJ, Butler WH, Mumford JP, Lewis PJ.
    J Child Neurol; 1991; Suppl 2():S17-24. PubMed ID: 1940119
    [Abstract] [Full Text] [Related]

  • 3. Vigabatrin in childhood epilepsy.
    Dulac O, Chiron C, Luna D, Cusmai R, Pajot N, Beaumont D, Mondragon S.
    J Child Neurol; 1991; Suppl 2():S30-7. PubMed ID: 1940122
    [Abstract] [Full Text] [Related]

  • 4. Vigabatrin in pediatric epilepsy--an open study.
    Uldall P, Alving J, Gram L, Beck S.
    J Child Neurol; 1991; Suppl 2():S38-44. PubMed ID: 1940123
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vigabatrin: a new antiepileptic medication.
    Mumford J, Dulac O.
    J Child Neurol; 1991; Suppl 2():S3-6. PubMed ID: 1940121
    [No Abstract] [Full Text] [Related]

  • 13. [Allergic vasculitis caused by Vigabatrin].
    Dieterle L, Becker EW, Berg PA, Berkenfeld R, Reinshagen G.
    Nervenarzt; 1994 Feb; 65(2):122-4. PubMed ID: 8164764
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology and clinical pharmacology of vigabatrin.
    Richens A.
    J Child Neurol; 1991 Feb; Suppl 2():S7-10. PubMed ID: 1940127
    [Abstract] [Full Text] [Related]

  • 15. A profile of vigabatrin.
    Mumford JP.
    Br J Clin Pract Suppl; 1988 Mar; 61():7-9. PubMed ID: 3145778
    [No Abstract] [Full Text] [Related]

  • 16. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
    Ylinen A.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report.
    Kälviäinen R, Aikiä M, Partanen J, Sivenius J, Mumford J, Saksa M, Riekkinen PJ.
    J Child Neurol; 1991 Dec; Suppl 2():S60-9. PubMed ID: 1940126
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical benefits of vigabatrin.
    Treiman DM.
    Br J Clin Pract Suppl; 1988 Mar; 61():24-9. PubMed ID: 3145773
    [No Abstract] [Full Text] [Related]

  • 20. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin.
    Lortie A, Chiron C, Mumford J, Dulac O.
    Neurology; 1993 Nov; 43(11 Suppl 5):S24-7. PubMed ID: 8232984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.